Status:
WITHDRAWN
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19
Lead Sponsor:
Henry Ford Health System
Conditions:
Covid-19
Eligibility:
All Genders
18-95 years
Brief Summary
This study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared fo...
Detailed Description
In response to the pandemic, the Food and Drug Administration (FDA) approved several platforms under emergency use authorization (EUA). These platforms do not have full FDA approval and may be used fo...
Eligibility Criteria
Inclusion
- Covid-19 testing has been ordered in the Emergency Dept. or for inpatients in the hospital or patient has already tested positive via PCR.
- Adult patients
- Consent obtained
Exclusion
- Testing not ordered or tested negative via PCR.
- Children
- Do not consent
Key Trial Info
Start Date :
May 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 9 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04403035
Start Date
May 10 2020
End Date
May 9 2021
Last Update
July 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ascension St. John Hospital
Detroit, Michigan, United States, 48236